Vivus stock price will reflect the following values:
(1) Qnexa approval USA + (2) Avanafil approval USA + (3) Qnexa approval Europe = $53 per share.
Then, we may see a buyout from a large phamaceutical at a 100% buyout premium at $106+
This week, we will be another week closer to:
(1) April 17th
(2) April 29th
(3) Qnexa approval in Europe
(4) Possible Vivus buyout or partnership
However, in the meantime, Vivus' stock price could come under pressure, and the price may drop some. It will be important to stay focused on the "big picture".
It will be harder and harder for some to stay focused on April 17th and April 29th. There will be a lot of negative chatter, and Vivus' share price may drip down some between now and April 17th.
However, we have seen this before. Just before the Adcomm on February 22nd, the same thing happened. It took a lot of focus and patience because there were a lot of false rumors and innuendoes floated. These were designed to steal Vivus shares at low prices...
Slap the mms and weak hands as hardest as you can, when they drop the price in IDIX, you will be glad you did. Be on stand by with cash and slap hard when it drops. they always play a nasty game and only deserves nothing but hard slap to be shut up.
The fact that Europe is asking for REMS type data from Vivus is a very good sign for Qnexa approval in Europe.
It sounds like the EMA CHMP is "dotting i's and cossing t's" before Qnexa approval.
In view of the update that Vivus released yesterday regarding the status of the Qnexa application in Europe, I am revising my "finish line" date from April 29th to May 25th.
Vivus' stock price will reflect Qnexa approval in the USA and Avanafil approval in the USA on April 29th. But, the approval of Qnexa in Europe probably won't be fully reflected in Vivus' stock price until May 25th.
Thanks dles.. I'm going to check this out.. that would be big news for me because I have been buying and selling for over 10 years and just totaling all gains and losses, minus deductions, and sending it in to Rev Can. Never heard of this 30 day thing before mario and mister mentioned it..
Ah well, ignorance is bliss! Have some homework to do...
I'm quite curious what Wilson meant by being opportunistic.. APRI has made me quite paranoid about dilution.. especially when it's done indiscriminately and side-swipes a potential run-up. I'm guessing that Vivus is smarter than that and will consider it's investors.. especially since it's 80% owned by institutions (maybe more now).
Your pain will end soon as soon as VVUS is $30/share
and you cover your $12 and $20 shorts. Going bankrupt heals a lot of worries since you basically don't have to worry about investing any more.
I feel some confidence in saying this from a technical analysis viewpoint because the VVUS market on Feb 24 showed a giant "envelopping candle " formation and on the 27th a giant inverted hammer which along with multiple gap ups are extremely bullish.
Do not forget to refresh your memory about Fat City USA the economic disaster that Obesity Type I,II and III has caused in the USA erectile dysfunction being one of them through causing Diabetes. The UAW is the biggest user of VIAGRA in the US and we taxpayers bailed them out.Money down the drain.
Salvation is near though through Fat Suits and Professor Bazef
1. Ten Fat Law Suits (including 2 threatened ones) Have Been Successful -- While One is Still Pending
3.And....the Professor himself
Banzaf with QNEXA/VVUS will finally stem the economic hemorhhage paid to fix blocked arteris, strokes heart attacks erectile dysfunction, diabetes dialysis and blindness,
PS: If FDA does not approve QNEXA they should all be fired for malpractice for allowing millions of Obesity side effects ( heart attacks, heart failure, strokes, kidney disease, Obstructive Sleep Apnea, Peripheral vascular disease ) to go untreated because " they are worried about the eoccasional extremely rare side effects of QNEXA. This is the same as not giving out vaccines because on rare occasions somebody has a problem. The Black Plaque in the middle ages killed 20,000,000 ( 20 million ) people.
PS: Disclaimer: Donot follow my advice at any time as a guide to your investing.Do your own research and get the facts yourself.